GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (FRA:3E0) » Definitions » EV-to-EBITDA

Establishment Labs Holdings (FRA:3E0) EV-to-EBITDA : -21.39 (As of Jun. 20, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Establishment Labs Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Establishment Labs Holdings's enterprise value is €1,229.2 Mil. Establishment Labs Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €-57.5 Mil. Therefore, Establishment Labs Holdings's EV-to-EBITDA for today is -21.39.

The historical rank and industry rank for Establishment Labs Holdings's EV-to-EBITDA or its related term are showing as below:

FRA:3E0' s EV-to-EBITDA Range Over the Past 10 Years
Min: -241.89   Med: -31.32   Max: -6.8
Current: -21.28

During the past 8 years, the highest EV-to-EBITDA of Establishment Labs Holdings was -6.80. The lowest was -241.89. And the median was -31.32.

FRA:3E0's EV-to-EBITDA is ranked worse than
100% of 480 companies
in the Medical Devices & Instruments industry
Industry Median: 15.3 vs FRA:3E0: -21.28

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-20), Establishment Labs Holdings's stock price is €34.00. Establishment Labs Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.907. Therefore, Establishment Labs Holdings's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Establishment Labs Holdings EV-to-EBITDA Historical Data

The historical data trend for Establishment Labs Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Establishment Labs Holdings EV-to-EBITDA Chart

Establishment Labs Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial -22.80 -34.22 -61.39 -30.24 -14.19

Establishment Labs Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.57 -46.92 -27.84 -14.19 -24.53

Competitive Comparison of Establishment Labs Holdings's EV-to-EBITDA

For the Medical Devices subindustry, Establishment Labs Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Establishment Labs Holdings's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's EV-to-EBITDA falls into.



Establishment Labs Holdings EV-to-EBITDA Calculation

Establishment Labs Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1229.214/-57.455
=-21.39

Establishment Labs Holdings's current Enterprise Value is €1,229.2 Mil.
Establishment Labs Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-57.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Establishment Labs Holdings  (FRA:3E0) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Establishment Labs Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=34.00/-2.907
=At Loss

Establishment Labs Holdings's share price for today is €34.00.
Establishment Labs Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.907.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Establishment Labs Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Establishment Labs Holdings (FRA:3E0) Business Description

Traded in Other Exchanges
Address
Coyol Free Zone, Building B15 and 25, Alajuela, CRI
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Establishment Labs Holdings (FRA:3E0) Headlines

No Headlines